Comerica Bank’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-124,262
| Closed | -$6.52M | – | 2375 |
|
|
2020
Q3 | $6.52M | Sell |
124,262
-298
| -0.2% | -$12.3K | 0.05% | 451 |
|
|
2020
Q2 | $3.97M | Buy |
124,560
+14,019
| +13% | +$446K | 0.03% | 651 |
|
|
2020
Q1 | $3.54M | Buy |
110,541
+3,944
| +4% | +$110K | 0.03% | 603 |
|
|
2019
Q4 | $3.18M | Buy |
106,597
+13,876
| +15% | +$222K | 0.02% | 809 |
|
|
2019
Q3 | $1.34M | Buy |
92,721
+85
| +0.1% | +$1.03K | 0.01% | 1349 |
|
|
2019
Q2 | $901K | Sell |
92,636
-4,862
| -5% | -$64.6K | 0.01% | 1597 |
|
|
2019
Q1 | $1.44M | Buy |
97,498
+5,690
| +6% | +$72.7K | 0.01% | 1346 |
|
|
2018
Q4 | $1.05M | Buy |
91,808
+15,776
| +21% | +$220K | 0.01% | 1528 |
|
|
2018
Q3 | $1.05M | Sell |
76,032
-5,968
| -7% | -$161K | 0.01% | 1561 |
|
|
2018
Q2 | $2.35M | Buy |
82,000
+1,242
| +2% | +$26.7K | 0.02% | 1155 |
|
|
2018
Q1 | $1.65M | Buy |
80,758
+2,496
| +3% | +$41.6K | 0.01% | 1342 |
|
|
2017
Q4 | $1.27M | Sell |
78,262
-2,287
| -3% | -$30.9K | 0.01% | 1520 |
|
|
2017
Q3 | $1.16M | Buy |
80,549
+9,899
| +14% | +$165K | 0.01% | 1540 |
|
|
2017
Q2 | $1.19M | Sell |
70,650
-1,225
| -2% | -$18.6K | 0.01% | 1487 |
|
|
2017
Q1 | $1.01M | Buy |
71,875
+3,652
| +5% | +$57.2K | 0.01% | 1603 |
|
|
2016
Q4 | $1.1M | Buy |
68,223
+4,817
| +8% | +$63.6K | 0.01% | 1539 |
|
|
2016
Q3 | $723K | Sell |
63,406
-24
| -0% | -$282 | 0.01% | 1653 |
|
|
2016
Q2 | $776K | Buy |
63,430
+155
| +0.2% | +$1.6K | 0.01% | 1630 |
|
|
2016
Q1 | $606K | Sell |
63,275
-339
| -0.5% | -$3.65K | 0.01% | 1688 |
|
|
2015
Q4 | $921K | Buy |
63,614
+312
| +0.5% | +$5.22K | 0.01% | 1457 |
|
|
2015
Q3 | $1.04M | Sell |
63,302
-56,792
| -47% | -$1.16M | 0.01% | 1414 |
|
|
2015
Q2 | $2.74M | Buy |
120,094
+72,071
| +150% | +$1.44M | 0.01% | 1335 |
|
|
2015
Q1 | $730K | Sell |
48,023
-42,731
| -47% | -$555K | 0.01% | 1623 |
|
|
2014
Q4 | $1.09M | Buy |
90,754
+45,074
| +99% | +$515K | ﹤0.01% | 1727 |
|
|
2014
Q3 | $518K | Buy |
45,680
+308
| +0.7% | +$3.51K | ﹤0.01% | 1757 |
|
|
2014
Q2 | $548K | Sell |
45,372
-841
| -2% | -$9.93K | ﹤0.01% | 1767 |
|
|
2014
Q1 | $538K | Sell |
46,213
-1,627
| -3% | -$27.6K | ﹤0.01% | 1837 |
|
|
2013
Q4 | $846K | Sell |
47,840
-1,328
| -3% | -$22.3K | 0.01% | 1640 |
|
|
2013
Q3 | $708K | Buy |
49,168
+1,418
| +3% | +$21.7K | ﹤0.01% | 1833 |
|
|
2013
Q2 | $719K | Buy |
+47,750
| New | +$630K | 0.01% | 1568 |
|
Comerica Bank's MNTA Position: Q4 2020 in Review
Comerica Bank sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 124,262 shares — an estimated $6.52M sold.
Comerica Bank first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $6.52M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Comerica Bank reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Comerica Bank sold 124,262 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $6.52M.
- Comerica Bank first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Comerica Bank's Momenta Pharmaceuticals, Inc. position peaked at $6.52M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Comerica Bank's 13F filing for Q4 2020, filed 28 Jan 2021.